Franklin Resources
TBIO

Franklin Resources’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Franklin Resources’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-132,208
Closed -$4.28M – 2432
2022
Q2 		$4.28M Sell
132,208
-21,484
-14% -$1.48M ﹤0.01% 1143
2022
Q1 		$14.9M Buy
153,692
+102,493
+200% +$15.5M 0.01% 923
2021
Q4 		$9.95M Buy
51,199
+10,482
+26% +$1.63M ﹤0.01% 1068
2021
Q3 		$8.16M Buy
40,717
+10,206
+33% +$2.59M ﹤0.01% 1099
2021
Q2 		$12.1M Buy
+30,511
New +$10.8M ﹤0.01% 981

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Franklin Resources's TBIO Position: Q3 2022 in Review

Franklin Resources sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2022, closing a stake of 132,208 shares — an estimated $4.28M sold.

Franklin Resources first reported a position in TBIO in Q2 2021 and held it in 5 quarters. The position peaked at $14.9M in Q1 2022. 32 funds tracked by Wall St. Rank hold TBIO as of Q3 2022.

  • Franklin Resources reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Franklin Resources sold 132,208 Telesis Bio, Inc. Common Stock shares in Q3 2022, an estimated $4.28M.
  • Franklin Resources first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Franklin Resources's Telesis Bio, Inc. Common Stock position peaked at $14.9M in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2022.

Based on Franklin Resources's 13F filing for Q3 2022, filed 14 Nov 2022.